AI Figures for Clinical AI Papers: Patient Cohorts, Diagnostic Pipelines, and Outcome Plots (2026)

It is 6:40 a.m. on submission day. A clinical-research fellow is sitting in front of a STARD flowchart she sketched on the back of a printout three weeks ago, trying to redraw it cleanly in PowerPoint before the 9 a.m. portal cut-off. The boxes don't line up. The "excluded — 47 patients" arrow points the wrong way. Her senior author has just emailed asking whether the diagnostic accuracy figure also shows calibration. She has ninety minutes.

This is the daily reality of figure preparation for a clinical AI paper, and it has very little in common with the figure preparation for a basic-science paper. The figures aren't decorative — they are part of the reporting structure that reviewers at Nature Medicine, JAMA, and The Lancet explicitly look for. A missing CONSORT-AI flowchart is not a stylistic issue; it is a reason for editorial rejection. This guide is for the people who have to produce those figures, and who would like to stop redrawing them by hand.

Key takeaways

Clinical AI figures sit inside a reporting-standards framework (CONSORT-AI, TRIPOD-AI, STARD, IDEAL) that journals treat as structural — not optional. Your figures need to communicate study design in a form a reviewer can audit.
The figure types repeat across papers: patient-flow diagrams, model-development flowcharts, segmentation pipelines, ROC / PR / calibration plots, decision curves, forest plots, and Kaplan-Meier curves. The variety is in the content, not the form.
AI figure tools are now strong enough to draft these figures from a spreadsheet, a sketch, or a parent-trial reference — and produce editable vector output (SVG, PDF) you can finish in a canvas instead of round-tripping to Illustrator.
AI cannot certify clinical claims. It can draw a forest plot but it cannot compute the correct subgroup confidence intervals, and it cannot anonymize a patient image for you. The figure illustrates; you remain responsible.
Disclosure of AI involvement in figure preparation is expected in 2026 across most clinical journals. A one-line statement in the methods or figure caption is the safest practice.

What clinical AI figures must do

A clinical AI figure is doing four jobs at once, and that's what makes them harder to produce than a basic-science schematic.

First, the figure has to communicate the study design clearly enough that a reviewer can replicate the analysis on paper. A CONSORT diagram is not just decoration — it is the canonical way the reviewer audits how patients moved from screening to analysis. A reader who can't trace that flow can't evaluate the paper.

Second, the figure has to satisfy a reporting standard. CONSORT-AI extends CONSORT for AI interventions; TRIPOD-AI does the same for prediction-model studies; STARD covers diagnostic accuracy; IDEAL governs surgical and device-staged evaluation. The journal's editorial office checks against these. If the flowchart is missing the AI-specific items (input handling, intended use, on-site performance, error analysis), the manuscript can stall in technical screening.

Third, the figure has to depict the AI pipeline transparently. Reviewers want to see input modality, preprocessing, model class, training and validation cohorts, and where the model meets clinical workflow. A "black box" arrow from "patient data" to "prediction" is the fastest way to invite a reject-and-resubmit.

Fourth, the figure has to show calibration, not only discrimination. AUC alone is now treated as insufficient at high-tier clinical journals. Calibration plots and decision-curve analyses are increasingly expected as part of the same figure or its companion supplementary panel.

The figure types you keep redrawing

If you spend an afternoon in the archives of Nature Medicine or JAMA, the figure inventory for a clinical AI paper is remarkably stable. The same shapes show up paper after paper:

CONSORT / CONSORT-AI patient-flow diagrams — vertical top-to-bottom flow from enrolment, through allocation, follow-up, and analysis, with side-branch exclusions at every stage.
TRIPOD-AI model development flowcharts — data sources → cohort definition → splits (training / tuning / temporal or geographic external validation) → model class → outcomes → performance.
STARD diagnostic study flowcharts — eligible patients, index test, reference standard, indeterminate / missing results, and the 2×2 contingency that feeds the accuracy estimates.
Patient cohort selection figures — inclusion and exclusion criteria expressed as a funnel, often with subgroup callouts (sex, age, comorbidity, scanner vendor).
Medical-imaging segmentation pipeline schematics — CT or MRI slice → preprocessing → U-Net / nnU-Net / transformer → predicted mask → overlay against radiologist ground truth.
ROC, precision-recall, and calibration plots — typically grouped on the same figure panel for comparison across model variants or against a clinical baseline.
Decision-curve analyses — net benefit as a function of threshold probability, with model, treat-all, and treat-none reference curves.
Forest plots for subgroup analyses — point estimates with confidence intervals stratified by site, demographic, or imaging vendor — used to argue performance generalizes.
Kaplan-Meier survival curves — for outcomes papers, frequently with at-risk tables and log-rank p-values.

Almost every clinical AI manuscript needs three to five of these. They are visually conventional — which is precisely what makes them well-suited to AI assistance, and precisely why drawing them by hand at 2 a.m. is so unsatisfying.

Mapping each figure type to a LabFig workflow

The six input modes in a tool like LabFig map cleanly onto the figure types above. If you work primarily on clinical and diagnostic studies, the dedicated medical figure maker is tuned for exactly these CONSORT, STARD, and outcome-plot conventions. The trick is to pick the mode that matches the input you already have, instead of forcing every figure through a text prompt.

Text to Figure for CONSORT-style flowcharts — when you already have cohort numbers in a spreadsheet, describe the flow in natural language ("Assessed for eligibility: 1,284. Excluded: 312 — 187 did not meet inclusion criteria, 125 declined.") in the text-to-figure tool. It produces a structurally correct flowchart you can refine in the canvas. This is the fastest path when the patient counts are known.
Sketch to Figure for whiteboarded study designs — if your team has whiteboarded the eligibility → randomization → follow-up flow during a study-design meeting, a phone photo is a better input than a paragraph. The tool preserves your block layout and arrow direction while regularizing the geometry. This is the right mode early in a study.
Reference to Figure for matching a parent trial — secondary analyses of large trials often need to live visually next to the parent publication. A reference image lets the new figure adopt the parent paper's color family, stroke weight, and labelling convention without re-deriving it from scratch.
PDF to Figure for redrawing a complex flowchart from an old protocol PDF — when the original source files are gone (consortium handovers, lost lab archives, a retired co-author), use the PDF-to-figure converter to extract the figure from the protocol PDF and rebuild it as an editable vector. Always retain the citation chain.
Figure Enhancer for inheriting a figure from a multi-center collaborator — multi-center clinical AI studies routinely ship figures across institutions in mismatched styles. The Enhancer normalizes line weights, palette, and typography across collaborators without changing the underlying content. This is the lowest-risk way to harmonize a multi-author figure set.

For segmentation pipeline schematics specifically, Text to Figure works well when the architecture is conventional (U-Net, nnU-Net) and Sketch to Figure works better when you have a non-standard architecture you have already drawn for an internal slide deck. For multi-omics or hybrid clinical-AI workflows that span imaging plus tabular plus genomic data, you may find our companion posts on AI figures for single-cell biology and AI figures for machine learning papers more directly relevant — the figure grammar is closer to those domains than to a pure clinical trial.

For ROC, PR, calibration, and decision-curve plots, the most reliable workflow is to export the numerical data from your modelling code (Python, R), then use Reference to Figure with one of your previous papers as a style anchor. This keeps the statistical accuracy entirely in your hands — the figure is a re-skin, not a recomputation. That separation matters; we return to it under limitations below.

Reporting standards that shape your figures

The figure types in a clinical AI paper are largely determined by the reporting standard the manuscript is written against. Treating these as upstream constraints — rather than as cleanup work at submission — is the single biggest workflow win.

CONSORT-AI is the AI-specific extension of CONSORT for randomized trials of AI interventions. It adds items on the AI intervention's intended use, input handling, on-site performance, human-AI interaction, and error analysis. The current consolidated guidance is hosted by the CONSORT-SPIRIT initiative, which also publishes the SPIRIT-AI extension for trial protocols. Most journals now reference CONSORT-AI directly in their submission checklists.
TRIPOD-AI extends TRIPOD for prediction-model studies that use AI/ML methods. It shapes the model-development flowchart specifically — what's required is a clear depiction of data sources, cohort definition, training / tuning / external validation splits, and the model class and inputs.
STARD is the reporting standard for diagnostic accuracy studies, and its flow diagram is essentially mandatory when a paper makes a diagnostic claim. The 2×2 of true / false positives and negatives, with explicit handling of indeterminate results, is the structural core.
IDEAL covers staged evaluation of surgical and complex device interventions — including some AI-enabled clinical decision-support systems — and its figures often reflect a stage (1 Idea → 2 Development → 3 Exploration → 4 Assessment → 5 Long-term study) framework.

The umbrella organization for almost all of these is the EQUATOR Network, which maintains a continuously updated registry of reporting guidelines. Nature Medicine's editorial position, summarized on its author hub, is that clinical AI submissions are expected to reference the relevant reporting standard explicitly; JAMA's author instructions are even more direct about CONSORT, STARD, and TRIPOD compliance, and require the relevant flow diagram as a manuscript element, not an optional figure.

This is why the figure you draft for a clinical AI paper is not really a creative decision. The structure is given. What AI helps with is producing the structure cleanly the first time, so you spend your reviewing energy on the content (patient counts, splits, intervals) instead of on layout.

Limitations: where AI struggles with clinical figures

Generative AI tools are useful for clinical figures in 2026, but a few limitations are sharper here than in basic-science work — and pretending they don't exist will get a paper rejected.

Regulatory-compliant figures (FDA SaMD, MDR class IIa/IIb). If your paper is companion to a Software-as-a-Medical-Device submission, the figures may need to align with the regulator's specific format expectations (intended-use statement, indications, user interface depiction). AI tools can draft these, but they cannot substitute for a regulatory affairs review. Treat the AI output as a first pass to be checked by your regulatory lead.
HIPAA-safe and GDPR-safe figure preparation. Medical-imaging segmentation figures often originate from real patient scans. Even after model inference, the underlying image can contain identifying features (skull contour, dental work, tattoos, jewelry visible in incidental field of view). AI figure tools do not perform de-identification. Run a de-identification pipeline (DICOM tag scrub, defacing for head CT/MR, manual review of incidental anatomy) before any patient image enters a generation tool.
Statistical rigor lives outside the figure. The AI can render a forest plot with twelve subgroups and clean confidence intervals — but it does not compute the intervals. Subgroup analyses, multiplicity adjustments, and the choice between fixed and random effects are statistical decisions you make in your analysis code. The figure visualizes the result; it does not certify it.
Patient-specific anonymization in figure captions. Captions sometimes include identifying details ("a 67-year-old male presenting with...") that are appropriate in a case report but not in cohort figures. The AI will faithfully render whatever caption you give it; the editorial responsibility for what belongs in the caption is yours.
Clinical claims cannot come from the figure. A beautifully rendered ROC curve does not make a model clinically ready. Decision-curve analyses, calibration in target populations, and prospective external validation are required before any clinical claim. The figure illustrates the evidence; it does not produce the evidence.

These are not arguments against using AI for clinical figures. They are arguments for keeping the figure as a rendering layer, with the science (data, statistics, ethics, regulation) cleanly upstream.

A workflow for your next paper

A concrete workflow that has worked for clinical AI papers in our experience, designed to respect reporting standards from the first generation rather than retrofit them at submission:

Pick the reporting standard before you pick the figure. Decide early whether the paper is a CONSORT-AI trial, a TRIPOD-AI prediction study, or a STARD diagnostic study. The standard determines which flowchart is mandatory. Reference the relevant checklist at the EQUATOR Network at this stage.
Sketch the patient-flow diagram on paper from the cohort numbers. Don't open a tool yet. Five minutes of pencil sketching is the cheapest way to lock the structural skeleton.
Generate the structural figures from the messiest input you have. Sketch to Figure for flowcharts; Reference to Figure for evaluation panels styled like a parent publication. Resist polishing — the goal of the first generation is structure, not finish.
Compute statistical content separately, then re-skin the plots. Generate ROC, PR, calibration, decision-curve, forest, and Kaplan-Meier plots from your analysis code (Python, R) with correct numbers. Use AI only to re-skin the visual style for journal consistency, not to fabricate the curve. This boundary protects the statistical integrity of the paper.
Edit the result in a vector canvas and export SVG + PDF. Once the structure is right, finish in the editor — labels, alignment, color, typographic legend. Export vector formats that survive copyediting. Keep the editable source for the inevitable round of revisions.

If you are setting up this workflow from scratch, our orientation post on AI for scientific figures covers the underlying tooling decisions, and the drug-discovery figures guide covers the visual conventions when your clinical AI paper sits adjacent to a translational pharmacology figure set.

FAQ

Can AI generate a CONSORT-AI compliant flow diagram? AI tools can produce the structural form of a CONSORT-AI diagram — the boxes, arrows, exclusion side-branches, and stage labels — from a spreadsheet of cohort numbers, and the visual result is now indistinguishable from a hand-drawn version. The compliance, however, is a content question: the diagram is CONSORT-AI compliant when its labels and the surrounding text address the AI-specific extension items (intended use, input handling, on-site performance, human-AI interaction, error analysis). The tool produces the figure; you produce the compliance.

How do I handle patient-image anonymization in segmentation figures? Anonymization must happen before the image enters any AI figure tool, not as part of it. Standard practice is to run a DICOM-tag scrub, apply defacing for head imaging, crop out incidental identifying anatomy (jewelry, tattoos, dental work visible in field of view), and have a second reader confirm de-identification on every image that will appear in the figure. AI figure tools do not perform de-identification and should not be relied on for it.

Are AI-generated clinical figures accepted at Nature Medicine, JAMA, or The Lancet? None of the major clinical journals have banned AI-assisted figure production as of 2026. Their published author instructions (Nature Medicine, JAMA) expect the figure itself to meet the journal's technical specifications and to satisfy the relevant reporting standard, and most explicitly request disclosure of AI involvement. The figure is judged on scientific and visual merit; how it was produced is a disclosure question, not an acceptance one.

What's the best way to generate calibration and decision-curve plots? Calibration and decision-curve plots are statistical artifacts — generate the data from your modelling code (R's rms package or Python's scikit-learn plus dcurves) and import the numerical output into an AI figure tool only for visual styling. Treating the plot as a "re-skin" of numbers you computed yourself preserves statistical integrity and avoids the failure mode of an AI-generated curve that looks plausible but is decoupled from your data.

Should AI involvement in figure preparation be disclosed in clinical trials? In 2026 the safest answer is yes. Most leading clinical journals expect a brief disclosure in the methods or figure caption — for example, "Figure 1 was drafted with an AI-assisted scientific illustration tool from the cohort spreadsheet and edited manually by the authors; statistical results are unchanged." The cost of over-disclosing is zero. The cost of under-disclosing, particularly for a clinical trial, can extend beyond the paper to your institution and IRB.